Sunil S. Raikar

PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity

Christopher Ronald Funk, Shuhua Wang, Kevin Z. Chen et al. · Blood · 2022 · 132 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists

Christopher T. Petersen, Mojibade Hassan, Anna B. Morris et al. · Blood Advances · 2018 · 106 citations · Full text

Medicine, Oncology, Pharmacology +15

Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell lines

Sunil S. Raikar, Lauren Fleischer, Robert Moot et al. · OncoImmunology · 2017 · 88 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia

Hope Mumme, Beena Thomas, Swati S. Bhasin et al. · Nature Communications · 2023 · 71 citations · Full text

Medicine, Hematology, Oncology +17

Allogeneic gamma delta T cells as adoptive cellular therapy for hematologic malignancies

Navdeep Jhita, Sunil S. Raikar · Exploration of Immunology · 2022 · 46 citations · Full text

Life Sciences, Immunology, Oncology +17